|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to cash provided by (used in) operating activities: | |||||
| Change in future policy benefits and other policy liabilities | |||||
| Deferral of policy acquisition costs | |||||
| Amortization of deferred policy acquisition costs | |||||
| Deferred tax provision | |||||
| Change in income taxes | |||||
| Investment (gains) losses | |||||
| Accretion and amortization of investments | |||||
| Depreciation and amortization | |||||
| Change in reinsurance recoverables | |||||
| Change in agent balances, due premiums and other receivables | |||||
| Change in renewal commissions receivable | |||||
| Trading securities sold, matured, or called (acquired), net | |||||
| Share-based compensation | |||||
| Impairment of goodwill and other long-lived assets | |||||
| Gain on insurance proceeds received from acquisition representation and warranty policy | |||||
| Loss on disposal of discontinued operations, excluding income tax benefit | |||||
| Change in other operating assets and liabilities, net | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Available-for-sale investments sold, matured or called: | |||||
| Fixed-maturity securities — sold | |||||
| Fixed-maturity securities — matured or called | |||||
| Short-term investments — sold | |||||
| Short-term investments — matured or called | |||||
| Equity securities - sold | |||||
| Equity securities - matured or called | |||||
| Available-for-sale investments acquired: | |||||
| Fixed-maturity securities | |||||
| Short-term investments | |||||
| Equity securities — acquired | |||||
| Purchases of property and equipment and other investing activities, net | |||||
| Cash collateral received (returned) on loaned securities, net | |||||
| Sales (purchases) of short-term investments using securities lending collateral, net | |||||
| Insurance proceeds received from acquisition representation and warranty policy | |||||
| Disposal of cash in discontinued operations | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Dividends paid | |||||
| Common stock repurchased | |||||
| Excise tax paid on common stock repurchased | |||||
| Tax withholdings on share-based compensation | |||||
| Finance leases | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange rate changes on cash | |||||
| Change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Income taxes paid | |||||
| Interest paid | |||||
Loading...
